| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.56B | 6.08B | 5.10B | 5.66B | 8.64B | 5.11B |
| Gross Profit | 2.75B | 1.92B | 2.83B | 3.33B | 5.55B | 3.25B |
| EBITDA | 3.64B | 3.33B | 2.74B | 3.39B | 4.25B | 1.98B |
| Net Income | 1.45B | 1.28B | 1.12B | 1.60B | 2.30B | 786.60M |
Balance Sheet | ||||||
| Total Assets | 15.82B | 15.76B | 13.10B | 12.38B | 11.62B | 11.38B |
| Cash, Cash Equivalents and Short-Term Investments | 4.10M | 7.00M | 0.00 | 1.10M | 57.10M | 0.00 |
| Total Debt | 3.76B | 4.83B | 2.39B | 2.21B | 1.79B | 2.57B |
| Total Liabilities | 7.21B | 7.49B | 5.15B | 4.96B | 4.97B | 5.45B |
| Stockholders Equity | 8.61B | 8.26B | 7.95B | 7.43B | 6.65B | 5.93B |
Cash Flow | ||||||
| Free Cash Flow | 1.22B | 1.26B | 546.90M | 567.80M | 2.41B | 953.90M |
| Operating Cash Flow | 3.13B | 3.09B | 2.35B | 2.39B | 3.83B | 2.01B |
| Investing Cash Flow | -3.74B | -3.54B | -1.91B | -1.69B | -1.41B | -808.10M |
| Financing Cash Flow | 609.90M | 449.50M | -443.50M | -759.60M | -2.36B | -1.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | C$5.49B | 8.13 | 16.78% | 5.77% | 29.94% | 57.11% | |
75 Outperform | C$20.32B | 213.66 | 7.70% | 6.33% | 80.64% | -50.20% | |
75 Outperform | C$26.12B | 9.80 | 4.40% | 4.79% | 7.06% | -45.27% | |
73 Outperform | C$17.60B | 7.04 | 17.43% | 2.95% | 17.91% | 11.40% | |
70 Outperform | C$10.39B | 57.81 | 13.89% | 2.99% | -24.78% | 5.03% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |